A Study to Assess the Effect of a Normal vs. High Protein Diets in Carbohydrates Metabolism in Obese Subjects With Diabetes or Prediabetes

Overview

The objective of the study is to assess the effect of low-calorie diets with normal (18%) vs. high (35%) protein (mainly coming from animal source) composition on body weight and carbohydrates metabolism in overweight and obese subjects with pre-diabetes or diabetes. A dietary intervention is carried out during 6 months in 100 subjects who are individually randomized to an energy-restricted diet with two types of macronutrients composition: 1) 35% protein, 30% fat and 35% carbohydrates and 2) 18% protein, 30% fat and 52% carbohydrates. Around 80% of total protein in diet comes from animal source (of whom around 40% from lean red meat). Subjects are provided with weekly menus and different recipes to use them as part of the diet. Monitoring visits with the nutritionist will be performed every 15 days. At the beginning of the study, after 3 and 6 months, the following parameters are determined: anthropometric (weight, waist circumference, body mass index and body composition), blood pressure, dietary (72-hours dietary registry) and exercise and biochemical analysis (total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol, apolipoproteins A1 and B, iron, transferring, ferritin, uric acid, glucose, HbA1c, insulin, adiponectin and resistin). Urine samples are also collected to assess microalbuminuria and ureic nitrogen.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: June 2017

Interventions

  • Behavioral: Weight loss interventional study with a low-calorie 18%-protein diet
  • Behavioral: Weight loss interventional study with a low-calorie 35%-protein diet

Arms, Groups and Cohorts

  • Active Comparator: 18%-Protein diet
    • Energy-restricted diet wit the following composition: 18% protein, 30% fat and 52% carbohydrates
  • Active Comparator: 35%-Protein diet
    • Energy-restricted diet wit the following composition: 35% protein, 30% fat and 35% carbohydrates

Clinical Trial Outcome Measures

Primary Measures

  • Change in glucose.
    • Time Frame: After 3 and 6 months of intervention.
  • Change in glycated hemoglobin.
    • Time Frame: After 3 and 6 months of intervention.
  • Change in insulin resistance (HOMA index).
    • Time Frame: After 3 and 6 months of intervention.

Secondary Measures

  • Change in body weight.
    • Time Frame: After 3 and 6 months of intervention.
  • Change in body composition.
    • Time Frame: After 3 and 6 months of intervention.
  • Change in waist circumference.
    • Time Frame: After 3 and 6 months of intervention.
  • Change in lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, non HDL cholesterol, triglycerides and apolipoproteins).
    • Time Frame: After 3 and 6 months of intervention.

Participating in This Clinical Trial

Inclusion Criteria

  • Age: 18-70 years old. – Body mass index between 27.5 – 40. – Steady weight (± 4 kg) in the last 2 months. – Glycated hemoglobin between 6 – 7%. Exclusion Criteria:

  • Anti-diabetic drugs (oral or subcutaneous) in the last 2 months. – Lipid-lowering drugs in the last 2 months. – Gouty arthritis in the last 2 years or uric acid > 735 mg/dl. – Presence of uncontrolled endocrinological pathology (including hypothyroidism). – Hepatic chronic disease (glomerular filtration rate < 45 ml/min). – Renal, inflammatory or tumoral diseases. – Drugs which could interfere in glucose or lipid metabolism such as androgens, corticosteroids (except for those with topic administration) and estrogen replacement therapy. – Intake of functional foods with plant sterols in the past 6 weeks. – High alcohol intake (> 30 g per day). – Any serious disease which involves less than 1 year life expectancy or, in investigators judgment, limit the follow-up of an homogeneous diet throughout the study. – Pregnancy or intention of pregnancy during the study.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 70 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Instituto Aragones de Ciencias de la Salud
  • Provider of Information About this Clinical Study
    • Principal Investigator: Fernando Civeira, Professor – Instituto Aragones de Ciencias de la Salud
  • Overall Official(s)
    • Fernando Civeira, MD, PhD, Principal Investigator, Unidad Clínica y de Investigación en Lípidos y Arteriosclerosis; Hospital U. Miguel Servet; IIS Aragón
  • Overall Contact(s)
    • Fernando Civeira, MD, PhD, +34 976765500, civeira@unizar.es

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.